The AGO2 adaptor LIMD1 expands the functional and evolutionary reach of microRNA targeting
Science Advances · 24.07.2026 · 12 (30)
DOI: 10.1126/sciadv.aed6875 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 24.07.2026. Verfasst von Alex F F Crozier und 14 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Cell and Molecular Biology, Barts Cancer Institute, Queen Mary University of London, London, UK. Hauptthemen laut MEDLINE: MicroRNAs, Argonaute Proteins, LIM Domain Proteins, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: City University London, Barts Charity, Medical Research Council.
Abstract (Originalsprache)
MicroRNA (miRNA) silencing is classically ascribed to RNA-sequence rules that guide Argonaute 2 (AGO2) targeting. Using chimeric eCLIP and complementary analyses in CRISPR-edited human lung epithelial cells, we show that efficient miRNA targeting also depends on the AGO2 adaptor-scaffold LIMD1. In LIMD1-deficient cells, AGO2 binds more miRNAs, but each AGO2-miRNA engages fewer transcripts and sites, reducing occupancy and halving both the breadth and depth of targeting. LIMD1 dependence is most pronounced for poorly conserved, weakly seed-paired sites that nonetheless form stable duplexes. LIMD1 deficiency alters AGO2 footprints and derepresses oncogenic targets inversely correlated with LIMD1 expression in lung adenocarcinoma. Thus, LIMD1 modifies the outcome of sequence-defined interactions that would otherwise be infrequent, unstable, or unproductive, revealing an adaptor-governed layer of posttranscriptional regulation beyond RNA-sequence rules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Cancer Cell and Molecular Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.
- Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
- Eclipse BioInnovations, San Diego, CA, USA.
- Cell Signalling and Proteomics Laboratory, Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK.
- York Biomedical Research Institute, University of York, York, UK.
- Department of Biochemistry, University of Oxford, South Parks Road, Oxford, UK.
ORCID-Profile: Alex F F Crozier, Kunal M Shah, Paul Grevitt, Anisha Thind, Eleni Maniati, Jun Wang, Kylie Shen, Vinothini Rajeeve, Pedro Cutillas, Dimitris Lagos, Faraz Mardakheh, Sam Griffiths-Jones, Antonio Marco, Tyson V Sharp
Förderung
- City University London
- Barts Charity
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- CRUK Animal Technician Service grant at Barts Cancer Institute
- CRUK FLOW CYTOMETRY CORE SERVICE and MICROSCOPY CORE SERVICE GRANT
- Cancer Research UK
- London Interdisciplinary Doctoral Training Programme
Zitieren
APA
Crozier, A. F. F., Shah, K. M., Grevitt, P., Thind, A., Maniati, E., Wang, J., Shen, K., Cox, D., Rajeeve, V., Cutillas, P., Lagos, D., Mardakheh, F., Griffiths-Jones, S., Marco, A., & Sharp, T. V. (2026). The AGO2 adaptor LIMD1 expands the functional and evolutionary reach of microRNA targeting. Science Advances, 12(30). https://doi.org/10.1126/sciadv.aed6875
Vancouver
Crozier AFF, Shah KM, Grevitt P, Thind A, Maniati E, Wang J, et al. The AGO2 adaptor LIMD1 expands the functional and evolutionary reach of microRNA targeting. Science Advances. 2026;12(30). doi:10.1126/sciadv.aed6875
BibTeX
@article{Crozier2026,
author = {Crozier, Alex F F and Shah, Kunal M and Grevitt, Paul and Thind, Anisha and Maniati, Eleni and Wang, Jun and Shen, Kylie and Cox, Diana and Rajeeve, Vinothini and Cutillas, Pedro and Lagos, Dimitris and Mardakheh, Faraz and Griffiths-Jones, Sam and Marco, Antonio and Sharp, Tyson V},
title = {The AGO2 adaptor LIMD1 expands the functional and evolutionary reach of microRNA targeting},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {30},
doi = {10.1126/sciadv.aed6875}
}
EUVIMED